Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. AbCellera Biologics Inc’s current trading price is -16.44% away from its 52-week high, while its distance from the 52-week low is 62.65%. The stock’s price range during this period has varied between $1.89 and $3.68. The company, active in the Healthcare sector, saw a trading volume of around 4.29 million for the day, considerably lower average daily volume of 4.6 million observed over the last three months.
The stock market performance of AbCellera Biologics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $3.68 on 01/22/25, while the lowest price during the same time frame was $1.89, recorded on 04/07/25.
How Financial Performance Impacts Market Capitalization
AbCellera Biologics Inc (ABCL) has experienced a quarterly rise of 21.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 917.84M and boasts a workforce of 596 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
How ABCL’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ABCL stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.
ABCL Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price gain of 4.95% this year. Over the last six months, there has been a weaker performance of 5.67%. The price of ABCL fallen by 52.23% during the last 30 days period. For the last 5-days stocks have improved 22.51%.
